GPCR logo

Structure Therapeutics Inc. (GPCR) EBIT

Annual EBIT:

-$158.23M-$55.45M(-53.96%)
December 31, 2024

Summary

  • As of today, GPCR annual earnings before interest & taxes is -$158.23 million, with the most recent change of -$55.45 million (-53.96%) on December 31, 2024.
  • During the last 3 years, GPCR annual EBIT has fallen by -$120.53 million (-319.75%).
  • GPCR annual EBIT is now -894.77% below its all-time high of -$15.91 million, reached on December 1, 2020.

Performance

GPCR EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGPCRincome statement metrics

Quarterly EBIT:

-$70.45M-$14.14M(-25.11%)
June 30, 2025

Summary

  • As of today, GPCR quarterly earnings before interest & taxes is -$70.45 million, with the most recent change of -$14.14 million (-25.11%) on June 30, 2025.
  • Over the past year, GPCR quarterly EBIT has dropped by -$37.13 million (-111.46%).
  • GPCR quarterly EBIT is now -443.94% below its all-time high of -$12.95 million, reached on March 1, 2022.

Performance

GPCR Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGPCRincome statement metrics

TTM EBIT:

-$219.66M-$37.13M(-20.35%)
June 30, 2025

Summary

  • As of today, GPCR TTM earnings before interest & taxes is -$219.66 million, with the most recent change of -$37.13 million (-20.35%) on June 30, 2025.
  • Over the past year, GPCR TTM EBIT has dropped by -$97.19 million (-79.36%).
  • GPCR TTM EBIT is now -1554.81% below its all-time high of -$13.27 million, reached on December 1, 2021.

Performance

GPCR TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGPCRincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

GPCR EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-54.0%-111.5%-79.4%
3Y3 Years-319.8%-404.7%-446.6%
5Y5 Years-894.8%-430.7%-1554.8%

GPCR EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-319.8%at low-443.8%at low-451.0%at low
5Y5-Year-894.8%at low-443.9%at low-1554.8%at low
All-TimeAll-Time-894.8%at low-443.9%at low-1554.8%at low

GPCR EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$70.45M(-25.1%)
-$219.66M(-20.3%)
Mar 2025
-
-$56.31M(-19.7%)
-$182.52M(-15.4%)
Dec 2024
-$158.23M(-54.0%)
-$47.06M(-2.7%)
-$158.23M(-11.3%)
Sep 2024
-
-$45.84M(-37.6%)
-$142.16M(-16.1%)
Jun 2024
-
-$33.32M(-4.1%)
-$122.47M(-6.4%)
Mar 2024
-
-$32.02M(-3.3%)
-$115.14M(-12.0%)
Dec 2023
-$102.78M
-$30.99M(-18.5%)
-$102.78M(-21.3%)
Sep 2023
-
-$26.14M(-0.6%)
-$84.74M(-44.6%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$25.99M(-32.3%)
-$58.59M(-25.8%)
Mar 2023
-
-$19.65M(-51.7%)
-$46.56M(-16.8%)
Dec 2022
-$52.56M(-39.4%)
-$12.96M(+7.2%)
-$39.87M(+0.8%)
Jun 2022
-
-$13.96M(-7.8%)
-$40.19M(-53.2%)
Mar 2022
-
-$12.95M(+2.4%)
-$26.23M(-97.6%)
Dec 2021
-$37.70M(-137.0%)
-
-
Dec 2021
-
-$13.27M
-$13.27M
Dec 2020
-$15.91M
-
-

FAQ

  • What is Structure Therapeutics Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. annual EBIT year-on-year change?
  • What is Structure Therapeutics Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. quarterly EBIT year-on-year change?
  • What is Structure Therapeutics Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. TTM EBIT year-on-year change?

What is Structure Therapeutics Inc. annual earnings before interest & taxes?

The current annual EBIT of GPCR is -$158.23M

What is the all-time high annual EBIT for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high annual earnings before interest & taxes is -$15.91M

What is Structure Therapeutics Inc. annual EBIT year-on-year change?

Over the past year, GPCR annual earnings before interest & taxes has changed by -$55.45M (-53.96%)

What is Structure Therapeutics Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of GPCR is -$70.45M

What is the all-time high quarterly EBIT for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high quarterly earnings before interest & taxes is -$12.95M

What is Structure Therapeutics Inc. quarterly EBIT year-on-year change?

Over the past year, GPCR quarterly earnings before interest & taxes has changed by -$37.13M (-111.46%)

What is Structure Therapeutics Inc. TTM earnings before interest & taxes?

The current TTM EBIT of GPCR is -$219.66M

What is the all-time high TTM EBIT for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high TTM earnings before interest & taxes is -$13.27M

What is Structure Therapeutics Inc. TTM EBIT year-on-year change?

Over the past year, GPCR TTM earnings before interest & taxes has changed by -$97.19M (-79.36%)
On this page